Skip to content

Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease

Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01562795
Enrollment
48
Registered
2012-03-26
Start date
2012-03-31
Completion date
2012-07-31
Last updated
2014-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderate to Severe Dry Eye Syndrome

Brief summary

This clinical trial is to investigate whether nonsteroid anti-inflammatory drops have therapeutic effect on moderate to severe dry eye patients.And compare the efficacy of the two nonsteroid anti-inflammatory drops with topical corticosteroids.

Interventions

DRUGnonsteroid anti-inflammatory drops

nonsteroid anti-inflammatory drops plus artificial tear substitute

DRUGcorticosteroids

corticosteroids plus artificial tear substitute

artificial tear substitute alone

Sponsors

Wenzhou Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* moderate to severe dry eye syndrome * tear film breakup time \>0 second and ≤5 seconds,or schirmer test(no anaesthesia)≥2mm/5min and ≤5mm/5min * corneal staining≥3 scores

Exclusion criteria

* allergic to any composition of the drugs under experiment * previous use of anti-inflammatory drugs or immunosuppressive agent * viral,bacterial or fungal infection of the eye * eyelid anomaly * glaucoma or high IOP * significant meibomian gland dysfunction

Design outcomes

Primary

MeasureTime frame
tear osmolarityDay 0, Day 14

Secondary

MeasureTime frame
corneal staining0 day,7th day and 14th day after treatment
Schirmer test(without anaesthesia)0 day,7th day,14th day after treatment
tear film breakup time(TBUT)0 day,7th day and 14th day after treatment
meibomian gland function0 day,7th day and 14th day after treatment

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026